早期非小细胞肺癌淋巴结清扫方式的研究进展
Research Progress of Lymph Node Dissection in Early Non-Small Cell Lung Cancer
摘要: 随着医疗水平技术的不断发展，越来越多的肺癌患者在发病早期被确诊。肺癌患者中却大部分都为非小细胞肺癌(non-small cell lung cancer, NSCLC)，目前手术切除肿瘤组织及淋巴结清扫已然成为肺癌的主要治疗手段，对于早期非小细胞肺癌是否要行淋巴结清扫，以及采用何种淋巴结清扫方式仍存在争议。本文拟就目前早期非小细胞肺癌根治术中淋巴结清扫方式及范围进行综述。
Abstract: With the continuous development of medical technology, more and more lung cancer patients are diagnosed in the early stage of the disease. However, most of the lung cancer patients are non-small cell lung cancer (NSCLC). At present, surgical resection of tumor tissue and lymph node dissection have become the main treatment methods for lung cancer. There are still controversies about whether lymph node dissection should be performed for early NSCLC and what kind of lymph node dissection should be adopted. This article reviews the methods and scope of lymph node dissection in early non-small cell lung cancer.
文章引用：郭乃强, 杜振宗. 早期非小细胞肺癌淋巴结清扫方式的研究进展[J]. 临床医学进展, 2022, 12(4): 2928-2933. https://doi.org/10.12677/ACM.2022.124422

参考文献

[1] De Leyn, P., Dooms, C., Kuzdzal, J., et al. (2014) Preoperative Mediastinal Lymph Node Staging for Non-Small Cell Lung Cancer: 2014 Update of the 2007 ESTS Guidelines. Translational Lung Cancer Research, 3, 225-233.
[2] Keller, S.M., Adak, S., Wagner, H., et al. (2000) Mediastinal Lymph Node Dissection Improves Survival in Patients with Stages II and IIIa Non-Small Cell Lung Cancer. Eastern Cooperative Oncology Group. The Annals of Thoracic Surgery, 70, 358-365. [Google Scholar] [CrossRef] 
[3] Galetta, D., Serra, M. and Spaggiari, L. (2008) Lymph-Node Dissection for the Treatment of Lung Cancer: Sampling or Complete Nodal Dissection? Lung Cancer, 60, 148-149. [Google Scholar] [CrossRef] [PubMed]
[4] Wang, Y. and Darling, G.E. (2017) Complete Mediastinal Lymph Node Dissection versus Systematic Lymph Node Sampling in Surgical Treatment of Non-Small Cell Lung Cancer: Do We Have the Answer? The Journal of Thoracic Disease, 9, 4169-4170. [Google Scholar] [CrossRef] [PubMed]
[5] Annema, J.T., Van Meerbeeck, J.P., Rintoul, R.C., et al. (2010) Mediastinoscopy vs Endosonography for Mediastinal Nodal Staging of Lung Cancer: A Randomized Trial. JAMA, 304, 2245-2252. [Google Scholar] [CrossRef] [PubMed]
[6] Okada, M., Tsubota, N., Yoshimura, M., et al. (1998) Proposal for Reasonable Mediastinal Lymphadenectomy in Bronchogenic Carcinomas: Role of Subcarinal Nodes in Selective Dissection. The Journal of Thoracic and Cardiovascular Surgery, 116, 949-953. [Google Scholar] [CrossRef] 
[7] Ishiguro, F., Matsuo, K., Fukui, T., et al. (2010) Effect of Selective Lymph Node Dissection Based on Patterns of Lobe-Specific Lymph Node Metastases on Patient Outcome in Patients with Resectable Non-Small Cell Lung Cancer: A Large-Scale Retrospective Cohort Study Applying a Propensity Score. The Journal of Thoracic and Cardiovascular Surgery, 139, 1001-1006. [Google Scholar] [CrossRef] [PubMed]
[8] Ma, W., Zhang, Z.J., Li, Y., et al. (2013) Comparison of Lobe-Specific Mediastinal Lymphadenectomy versus Systematic Mediastinal Lymphadenectomy for Clinical Stage T1aN₀M₀ Non-Small Cell Lung Cancer. Journal of Cancer Research and Therapeutics, 9, S101-S105. [Google Scholar] [CrossRef] [PubMed]
[9] Deng, H.Y., Qin, C.L., Li, G., et al. (2018) Can Lobe-Specific Lymph Node Dissection Be an Alternative to Systematic Lymph Node Dissection in Treating Early-Stage Non-Small Cell Lung Cancer: A Comprehensive Systematic Review and Meta-Analysis? Journal of Thoracic Disease, 10, 2857-2865. [Google Scholar] [CrossRef] [PubMed]
[10] Zhao, Y., Mao, Y., He, J., et al. (2021) Lobe-Specific Lymph Node Dissection in Clinical Stage IA Solid-Dominant Non-Small-Cell Lung Cancer: A Propensity Score Matching Study. Clinical Lung Cancer, 22, e201-e210. [Google Scholar] [CrossRef] [PubMed]
[11] Zhao, J.L., Nie, Y.Q., Yang, P., et al. (2021) Effect of Selective Lymph Node Dissection on Immune Function in Patients with T1 Stage Non-Small Cell Lung Cancer: A Randomized Controlled Trial. Translational Cancer Research, 10, 2918-2931. [Google Scholar] [CrossRef] [PubMed]
[12] Hishida, T., Miyaoka, E., Yokoi, K., et al. (2016) Lobe-Specific Nodal Dissection for Clinical Stage I and II NSCLC: Japanese Multi-Institutional Retrospective Study Using a Propensity Score Analysis. Journal of Thoracic Oncology: Official Publication of the International Association for the Study of Lung Cancer, 11, 1529-1537. [Google Scholar] [CrossRef] [PubMed]
[13] Wang, Z., Qi, Z., Cheng, D., et al. (2021) Lobe-Specific Node Dissection Can Be a Suitable Alternative to Systematic Lymph Node Dissection in Highly Selective Early-Stage Non-Small-Cell Lung Cancer Patients: A Meta-Analysis. Annals of Thoracic and Cardiovascular Surgery: Official Journal of the Association of Thoracic and Cardiovascular Surgeons of Asia, 27, 143-150. [Google Scholar] [CrossRef] [PubMed]
[14] Wang, W., Chen, D., Xi, K., et al. (2019) Impact of Different Types of Lymphadenectomy Combined with Different Extents of Tumor Resection on Survival Outcomes of Stage I Non-Small-Cell Lung Cancer: A Large-Cohort Real-World Study. Frontiers in Oncology, 9, Article No. 642. [Google Scholar] [CrossRef] [PubMed]
[15] Hata, E.H.K. and Miyamoto, H. (1990) Rationale for Extended Lymphadenectomy for Lung Cancer. Theoretical Surgery, 5, 19-25.
[16] Hata, E., Miyamoto, H., Tanaka, M., et al. (1994) Superradical Operation for Lung Cancer: Bilateral Mediastinal Dissection (BMD) with or without Cervical Dissection (CD). Lung Cancer, 11, 41-42. [Google Scholar] [CrossRef] 

为你推荐